The therapeutic benefits of MMP-12 shRNA treatment, especially on neurological and motor function recovery, were more apparent in young males than in young females, presumably because high estrogen levels in females are associated with stroke neuroprotection. The gene discussed is MMP12; the disease is stroke disorder.